CompuMed, Inc.
CompuMed, Inc. (CMPD) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
cmpd · pe ratio · data through Sep 30, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for CompuMed, Inc. (CMPD) measures how much investors pay for each dollar of the company's trailing earnings. CMPD's current PE ratio of N/A is calculated by dividing its stock price of $6.34 by its TTM earnings per share of -$0.19.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-09-30
PE Ratio History
2002 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 7 fiscal years · Front-end computedMinQ1 · 25%18.6x
MedianQ3 · 75%24.8x
Max
At N/A, CMPD's current P/E is lower than in 0% of its annual fiscal year readings over the past 7 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Healthcare Information Services · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
CompuMed, Inc.You CMPD | $8M | N/A | — | -$0.19 |
 Core One Labs Inc. CLABF | $0M | N/A | — | -$0.49 |
 Cann Group Limited CNGGF | $1M | N/A | — | -$0.04 |
 Mosaic ImmunoEngineering Inc. CPMV | $5M | N/A | — | -$0.10 |
 Dogecoin Cash, Inc. DOGP | $2M | N/A | — | -$0.00 |
 Evolutionary Genomics, Inc. FNAM | $0M | N/A | — | -$0.30 |
 HealthLynked Corp. HLYK | $8M | N/A | — | -$1.16 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-09-30Latest FY2025 | — | $-0.05 | — | |
2024-09-30 FY2024 | 24.81x | $0.15 | — | |
2023-09-30 FY2023 | — | $-0.02 | — | |
2022-09-30 FY2022 | 13.36x | $0.30 | +3.0% | |
2021-09-30 FY2021 | 12.97x | $0.69 | -35.1% | |
2020-09-30 FY2020 | 19.97x | $0.26 | +233.1% | |
2019-09-30 FY2019 | 5.99x | $0.75 | -72.4% | |
2018-09-30 FY2018 | 21.69x | $0.17 | +16.6% | |
2017-09-30 FY2017 | 18.59x | $0.07 | — | |
2016-09-30 FY2016 | — | $-0.11 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for CompuMed, Inc. (CMPD) measures how much investors pay for each dollar of the company's trailing earnings. CMPD's current PE ratio of N/A is calculated by dividing its stock price of $6.34 by its TTM earnings per share of -$0.19.
Frequently asked questions
CMPD pe ratio · 6 questionsCMPD's current PE ratio is N/A as of 2026-06-09, based on a stock price of $6.34 and TTM EPS of -$0.19. Data sourced from Financial Modeling Prep via CMPD's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · CompuMed, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09